Abstract
Psoriasis can run an unpredictable course. Some patients can get one, self limiting break out of the rash which may never recur again. Others can have chronic or relapsing flare ups of their psoriasis most of their life. Psoriasis may be very limited and mild in some patients, yet extensive and severe in others. Although there is as yet no cure for psoriasis, almost all patients can be managed by simple topical treatments at home. Some might need hospital based treatment such as UVL or systemic therapies. The improved understanding of the pathophysiology of psoriasis has led to the development of a number of targeted biological treatments which are extremely effective. Many of these new therapies are very expensive and can have side effects, especially in relation to their immunosuppressive effects. Patients with psoriasis have a higher incidence of obesity, hypertension, hypercholesterolaemia, diabetes, heart disease, depression, and the metabolic syndrome and they should be screened for these conditions.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Wolters M. Diet and psoriasis: experimental data and clinical evidence. Br J Dermatol. 2005;153(4):706–14.
Naldi L. Dietary factors and the risk of psoriasis. Results of an Italian case–control study. Br J Dermatol. 1996;134(1):101–6.
Phan C, Touvier M, Kesse-Guyot E, et al. Association between Mediterranean anti-inflammatory dietary profile and severity of psoriasis results from the NutriNet-Santé Cohort. JAMA Dermatol. 2018;154:1017–24. https://doi.org/10.1001/jamadermatol.2018.2127.
Kim GK, Del Rosso JQ. Drug provoked psoriasis: Is it drug induced or drug aggravated? Understanding pathophysiology and clinical relevance. J Clin Aesthetic Dermatol. 2010;3(1):32–8.
Kaur J. A comprehensive review on metabolic syndrome. Cardiol Res Pract. 2014;2014:943162. https://doi.org/10.1155/2014/943162.
Kurd SK, et al. The risk of depression, anxiety, and suicidality in patients with psoriasis: a population-based cohort study. Arch Dermatol. 2010;146(8):891–5. https://doi.org/10.1001/archdermatol.2010.186.
Koo J, et al. Superior efficacy of calcipotriene and betamethasone dipropionate aerosol foam versus ointment in patients with psoriasis vulgaris – A randomized phase II study. J Dermatol Treat. 2016;27:120–7.
Menter A, Korman NJ, Elmets CA, Feldman SR, Gelfand JM, Gordon KB, et al. Guidelines of care for the management of psoriasis and psoriatic arthritis. Section 3. Guidelines of care for the management and treatment of psoriasis with topical therapies. J Am Acad Dermatol. 2009;60(4):643–59. https://doi.org/10.1016/j.jaad.2008.12.032.
Laws PM, Young HS. Update of the management of chronic psoriasis: new approaches and emerging treatment options. Clin Cosmetic Investig Dermatol. 2010;3:25–37.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Buckley, D. (2021). Management of Psoriasis in Primary Care. In: Buckley, D., Pasquali, P. (eds) Textbook of Primary Care Dermatology. Springer, Cham. https://doi.org/10.1007/978-3-030-29101-3_15
Download citation
DOI: https://doi.org/10.1007/978-3-030-29101-3_15
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-29100-6
Online ISBN: 978-3-030-29101-3
eBook Packages: MedicineMedicine (R0)